/ Print /

ModernMedicine Resource Center More Topics

ovarian and breast cancer resource center

Regular use of low-dose aspirin may lower breast cancer riskThe medication’s ability to reduce inflammation sited as one possible explanation.
Number of women with metastatic breast cancer rising, as is survival rateStudy highlights the need for services and research for this understudied population.
PARP inhibitor shows promise in ovarian cancerStudy shows Clovis Oncology’s rucaparib shows clinically meaningful impact in delaying disease recurrence in ovarian cancer.
Racial disparity in breast cancer mortality linked to genesUnderstanding genetic variations and tumor differences in black women with breast cancer could lead to personalized diagnosis and treatment.
Ovarian cancer: Possible advantage of high blood pressureNew research shows hypertension, diabetes influence survival of ovarian cancer patients in different ways.
Surprising link found in black women breast cancer riskAlcohol consumption is known to be a risk factor for breast cancer based on studies predominantly done in white women. Now, a University of North Carolina Lineberger Comprehensive Cancer Center study has found the same risk exists for black women.
Asian-American women need better targeted breast cancer therapyA new study provides new insights into the epidemiology of breast cancer among the most prominent Asian-American ethnic groups in California.
Researchers identify more effective, cost-efficient test for breast cancer riskNew findings reveal this genetic test to assess breast cancer risk could be more effective than others.
New cancer care approach: Highmark’s cancer collaborativeCancer care has made great strides in the U.S., but effective care is still too expensive and inaccessible for many Americans. Now, payers and providers at Highmark, Allegheny Health Network and Johns Hopkins are launching a new model that could change cancer collaboration.
Re-evaluate coverage policies for breast cancerNew NCCN guidelines include new technology as an option for patients’ annual screening.